Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Innovative Pharmaceutical Biotech ( (HK:0399) ) just unveiled an announcement.
Innovative Pharmaceutical Biotech Limited has announced a share placement agreement with CNI Securities Group to issue up to 206,400,000 new shares at a price of HK$0.175 each, representing a discount to recent trading prices. The proceeds, estimated at approximately HK$35.52 million after expenses, will be used for general working capital, potentially enhancing the company’s financial flexibility and operational capacity.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited operates in the pharmaceutical and biotechnology industry, focusing on the development and commercialization of innovative medical treatments and products.
Average Trading Volume: 1,571,698
Technical Sentiment Signal: Buy
Current Market Cap: HK$393.6M
For an in-depth examination of 0399 stock, go to TipRanks’ Stock Analysis page.